12:00 AM
 | 
Jan 02, 2002
 |  BC Extra  |  Company News

GZMO, Genzyme Genetics IP deal

Genzyme Molecular (GZMO) transferred its cancer diagnostics IP to Genzyme Genetics, a business unit of Genzyme (GENZ). Genzyme Genetics ( Cambridge,...

Read the full 106 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >